Call for Abstracts
The Committee of the 70th Annual Meeting of the JSN encourages abstract submission widely from overseas. All the abstracts submitted are rated and selected for presentation by the Committee.
The abstract is only submitted by online. The submission of abstracts by e-mail will NOT be considered. The abstract should be written in English.
Regular Submission
| Nov. 4 (Wed), 2026 - | at 2:00 p.m. JST on Dec. 23 (Wed), 2026 |
Regular Submission
The deadline for regular submission is scheduled at 2:00 p.m. JST on Dec. 23 (Wed), 2026.
Please select preferred presentation style, Oral or Poster, when you submit an abstract.
However, please note that the presentation style will be decided by the congress chairperson.
Please note that encore abstracts and case report abstracts will NOT be accepted.
*Presentation style
Presentation language
Presentations must be given in either Japanese or English.
On-site presentation
Presentations must be given on site by the first author.
- Oral presentation:Presentation and discussion at venue (8mins Presentation+ 4mins Discussion, Total 12mins)
- Poster presentation:Displaying poster and discussion at venue (4mins Presentation+ 2mins Discussion, Total 6mins)
【Best Abstract Awards】
All the abstracts submitted are rated by the Abstract Review Committee and the Committee honors high scored abstracts with Best abstract awards.
The awardees are to present their research in English as Oral presentations.
*Application Review Considerations
All abstracts will be reviewed according to the same criteria. Acceptance of abstracts will be determined by the 2027 Congress Chairperson based on the reviews conducted by the Abstract Review Committee appointed by the Congress Chairperson.
Please note that the Congress does not provide financial support to authors of regular submissions. Authors of accepted abstracts are responsible for all expenses associated with attending the Congress, including transportation, accommodation, and registration fees.
1. Maximum number of authors and institutions
Authors: 18 persons (including the first author)
Institutions: 10 centers
2. Limitations of number of words
Abstract Title: 50 words
Abstract Body: 250 words
Total number of words (including authors, institutions, title and abstract body): 300 words
3. COI disclosure
When submitting your abstract, please indicate any conflicts of interest related to your research or publication by checking the appropriate box.
Please refer to the detailed regulations for further information.
4. Password
You are required to create a password. The password is case-sensitive and must be 6 to 8 characters long. The password is required to view or modify your abstract.
For security reasons, your password cannot be retrieved or provided by the secretariat. Please make sure to keep a copy of your password in a secure place when submitting your abstract.
5. Receipt of Abstract / Notifying the result
Receipt of abstract will be automatically sent to the registered e-mail address. We strongly advise you to confirm the contents that you submit.
The result of review will be notified all candidates via e-mail. Please make sure to register accurate e-mail address.
6. Category of Regular Submission
We accept submission of English abstracts to regular session.
| CKD | |
|---|---|
| 101 | CKD (non-dialysis; basic) |
| 102 | CKD (non-dialysis; clinical) |
| 103 | Anemia and iron metabolism |
| 104 | Others |
| ESRD | |
|---|---|
| 201 | Hemodialysis |
| 202 | Peritoneal dialysis |
| 203 | Renal transplantation |
| 204 | Apheresis |
| 205 | Others |
| AKI | |
|---|---|
| 301 | AKI (basic) |
| 302 | AKI (clinical) |
| Glomerular / Tubulointerstitial Diseases (Primary and Secondary included DKD) | |
|---|---|
| 401 | Primary glomerular diseases (basic) |
| 402 | Primary glomerular diseases (clinical) |
| 403 | Secondary glomerular diseases (basic) |
| 404 | Secondary glomerular diseases (clinical) |
| 405 | Tubulointerstitial diseases |
| 406 | Drug-induced kidney diseases (basic) |
| 407 | Drug-induced kidney diseases (clinical) |
| 408 | DKD (basic) |
| 409 | DKD (clinical) |
| 410 | Others |
| Pediatric / Genetic / Cystic / Urological Diseases | |
|---|---|
| 501 | Pediatric nephrology |
| 502 | Genetic kidney diseases: cystic |
| 503 | Genetic kidney diseases: non-cystic |
| 504 | Urological diseases |
| Fluid, Electrolyte, and Acid-base / Mineral and Bone Disorders | |
|---|---|
| 601 | Fluid, electrolytes, and acid-base disorders (basic) |
| 602 | Fluid, electrolytes, and acid-base disorders (clinical) |
| 603 | Bone and mineral diseases (basic) |
| 604 | Bone and mineral diseases (clinical) |
| Hypertension / Cardiovascular Diseases | |
|---|---|
| 701 | Hypertension (basic) |
| 702 | Hypertension (clinical) |
| 703 | Cardiovascular diseases (basic) |
| 704 | Cardiovascular diseases (clinical) |
| Interdisciplinary Care / Community Health Care | |
|---|---|
| 801 | Education and health guidance for CKD |
| 802 | Community Health Care |
| 803 | Laboratory medicine / AI |
| 804 | Others |
| Basic Science | |
|---|---|
| 901 | Genetics/Development |
| 902 | Stem Cells/Regeneration |
| 903 | Extracellular Matrix/Fibrosis |
| 904 | Immunity/Inflammation |
| 905 | Hormone/Cell Signaling |
| 906 | Others |
7. Keyword
Please state up to three keywords of your abstract. (at least one keyword is mandatory)
8. Submit, Confirm and Modify Abstracts
SSL
Non SSL
(If you cannot use cipher-text-based.)
